Galectin Therapeutics Inc (GALT) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

GALT rapporto: 65%

100%

GALT supera 22 di 34 ultime stime

Data del prossimo reportNov 11, 2024

Stimato per Q3 24:$-0.20

Cambiamenti implicati per il Q2 24:0.00%

Cambiamenti implicati per il Q3 23:-16.67%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q2 24	Aug 13, 2024	$-0.2 / $-0.16	$-0.04 / -25%
Q1 24	May 15, 2024	$-0.19 / $-0.16	$-0.03 / -18.75%
Q4 23	Mar 29, 2024	$-0.16 / $-	$0 / -
Q3 23	Nov 13, 2023	$-0.24 / $-0.16	$-0.08 / -50%
Q2 23	Aug 14, 2023	$-0.15 / $-0.21	$0.06 / 28.57%
Q1 23	May 15, 2023	$-0.19 / $-0.21	$0.02 / 9.52%
Q4 22	Mar 30, 2023	$-0.18 / $-0.17	$-0.01 / -5.88%
Q3 22	Nov 14, 2022	$-0.14 / $-0.2	$0.06 / 30%

Fornitori di Dati: Xignite Logo